UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of Syncope During Pregnancy: Temporal Trends and Outcomes

Journal of the American Heart Association, 2019-05, Vol.8 (10), p.e011608-e011608

2019

Volltextzugriff (PDF)

STEPping down diuretic therapy with semaglutide in obesity-related heart failure with preserved ejection fraction: decongestion or disease modification?

European heart journal, 2024-09, Vol.45 (35), p.3270-3273

2024

Volltextzugriff (PDF)

Response by Chatur et al to Letter Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial"

Circulation (New York, N.Y.), 2024-08, Vol.150 (6), p.e107

2024

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2024-03, Vol.83 (9), p.e89

2024

Volltextzugriff (PDF)

EFFECTS OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ON RENAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.308

2022

Volltextzugriff (PDF)

Give a nudge a shot: NUDGE‐FLU bridging the cardiovascular quality chasm

European journal of heart failure, 2023-08, Vol.25 (8), p.1459-1463

2023

Volltextzugriff (PDF)

Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathy

Current opinion in cardiology, 2023-09, Vol.38 (5), p.424-432

2023

Volltextzugriff (PDF)

Random admission urinary sodium for diuretic response: promise in pragmatism?

European journal of heart failure, 2022-10, Vol.24 (10), p.1988-1989

2022

Volltextzugriff (PDF)

EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.4605-4605

2024

Volltextzugriff (PDF)

How to Diagnose and Manage Radiation Cardiotoxicity

JACC CardioOncology, 2020-11, Vol.2 (4), p.655-660

2020

Volltextzugriff (PDF)

DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE FOLLOWING SACUBITRIL/VALSARTAN INITIATION IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM PARAGON-HF AND PARADIGM-HF

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.276-276

2023

Volltextzugriff (PDF)

Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF

Journal of cardiac failure, 2023-04, Vol.29 (4), p.670-670

2023

Volltextzugriff (PDF)

Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology

JACC CardioOncology, 2023-06, Vol.5 (3), p.329-331

2023

Volltextzugriff (PDF)

ELECTRONIC NUDGES TO INCREASE INFLUENZA VACCINATION UPTAKE AMONG PARTICIPANTS WITH HISTORY OF ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM NUDGE-FLU

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.1309-1309

2024

Volltextzugriff (PDF)

EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK IN TOPCAT AMERICAS

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.330-330

2024

Volltextzugriff (PDF)

Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function

Journal of the American College of Cardiology, 2023-11, Vol.82 (19), p.1854-1863

2023

Volltextzugriff (PDF)

Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract 17602: Cardiac Structure and Function and Renal Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the PARAGON-HF Trial

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure

Journal of the American College of Cardiology, 2024-06, Vol.83 (22), p.2148-2159

2024

Volltextzugriff (PDF)

Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure

Journal of the American College of Cardiology, 2023-04, Vol.81 (15), p.1443-1455

2023

Volltextzugriff (PDF)

PROPHYLACTIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN PATIENTS WITH CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES: ARE THEY COST-EFFECTIVE?

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.3076-3076

2019

Volltextzugriff (PDF)

RVX-208

Journal of the American College of Cardiology, 2010-06, Vol.55 (23), p.2580-2589

2010

Volltextzugriff (PDF)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial

European journal of heart failure, 2023-01, Vol.25 (1), p.87-94

2023

Volltextzugriff (PDF)

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF

European journal of heart failure, 2022-05, Vol.24 (5), p.794-803

2022

Volltextzugriff (PDF)

RVX-208: A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo

Journal of the American College of Cardiology, 2010-06, Vol.55 (23), p.2580-2589

2010

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Incidence of Syncope During Pregnancy: Temporal Trends and Outcomes

STEPping down diuretic therapy with semaglutide in obesity-related heart failure with preserved ejection fraction: decongestion or disease modification?

Response by Chatur et al to Letter Regarding Article, "Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial"

Reply

EFFECTS OF SACUBITRIL/VALSARTAN VERSUS VALSARTAN ON RENAL FUNCTION IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: PARAGON-HF

Give a nudge a shot: NUDGE‐FLU bridging the cardiovascular quality chasm

Monitoring treatment with cardiac myosin inhibitors in symptomatic obstructive hypertrophic cardiomyopathy

Random admission urinary sodium for diuretic response: promise in pragmatism?

EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK

How to Diagnose and Manage Radiation Cardiotoxicity

DECLINE IN ESTIMATED GLOMERULAR FILTRATION RATE FOLLOWING SACUBITRIL/VALSARTAN INITIATION IN PATIENTS WITH HEART FAILURE: INSIGHTS FROM PARAGON-HF AND PARADIGM-HF

Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF

Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology

ELECTRONIC NUDGES TO INCREASE INFLUENZA VACCINATION UPTAKE AMONG PARTICIPANTS WITH HISTORY OF ACUTE MYOCARDIAL INFARCTION: INSIGHTS FROM NUDGE-FLU

EFFECTS OF SPIRONOLACTONE IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK IN TOPCAT AMERICAS

Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function

Abstract 12470: Sacubitril/Valsartan in Patients With Heart Failure and Deterioration of Kidney Function to Estimated Glomerular Filtration Rate Less Than 30ml/min/1.73m 2 : Insights From PARAGON-HF and PARADIGM-HF

Abstract 17602: Cardiac Structure and Function and Renal Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: Insights From the PARAGON-HF Trial

Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure

Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure

PROPHYLACTIC IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN PATIENTS WITH CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES: ARE THEY COST-EFFECTIVE?

RVX-208

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial

Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF

RVX-208: A Small Molecule That Increases Apolipoprotein A-I and High-Density Lipoprotein Cholesterol In Vitro and In Vivo

Suchergebnisse filtern